FindTrial
Sign In

Evaluation of the Effect and Analysis of Influencing Factors of Hepatitis B Vaccine Combined with Hepatitis B Immunoglobulin in Blocking Mother-to-Child Transmission of Hepatitis B in Jilin Province

Evaluation of the Effect and Analysis of Influencing Factors of Hepatitis B Vaccine Combined with Hepatitis B Immunoglobulin in Blocking Mother-to-Child Transmission of Hepatitis B in Jilin Province

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600122715
Enrollment
Unknown
Registered
2026-04-16
Start date
2025-09-18
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis B

Interventions

Single Immunotherapy Group:None
Combined Immunotherapy Group:None

Sponsors

Jilin Provincial Center for Disease Control and Prevention(Jilin Provincial Academy of Preventive Medicine)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Hospitalized HBsAg-positive parturients and their neonates across counties and districts of Jilin Province in 2022 were enrolled as study subjects.

Exclusion criteria

Exclusion criteria: 1. multiparous status with HBV infection; 2. twin or multiple gestations; 3. clinically evident liver function impairment; 4. poor adherence to management; 5. concurrent HCV, HEV, or HIV co-infections.

Design outcomes

Primary

MeasureTime frame
HBsAg positive rate;—

Countries

China

Contacts

Public ContactWu Yi

Jilin Provincial Center for Disease Control and Prevention(Jilin Provincial Academy of Preventive Medicine)

646336153@qq.com+86 431 87977361

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026